Mumbai, Dec 20 (PTI) Fertility treatments chain Indira IVF on Tuesday announced a foray into the diagnostics sector with a Rs 60 crore investment over the next five years.

The city-based company, which claims to India's largest fertility treatments chain, plans to offer pathology tests catering to the needs of women and children, as per an official statement.

Also Read | Hyundai Kona Next Generation Globally Unveiled With New Powertain Options; Check Out All Details Here.

It plans to have over 30 laboratories by FY24, which will include centres in Lucknow, Patna, New Delhi, Mumbai, Pune, Udaipur, Jaipur, Varanasi, Kolkata, Ranchi, Bhubaneswar and Bengaluru, it said.

The TA Associates-backed chain plans to invest Rs 50-60 crore for Indira Pathlabs over next five years which may even exceed depending on future plans and opportunities, the statement said.

Also Read | iQOO 11 5G, Touted as World’s Fastest Smartphone, Coming to India Soon: Know Unparalleled Features and Launch Date Here.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)